Bristol Myers Squibb AI case studies

Browse 5 documented AI medicine implementations at Bristol Myers Squibb. These source-extracted records passed the automated evidence gate; that is not independent fact verification.

Pharmaceutical & Life Science · Enterprise · 5 AI implementations

Bristol Myers Squibb has 5 documented AI medicine implementations covering workflows including Drug Discovery & Development, Clinical Trials & Research and technology including Machine Learning & Predictive Analytics, Large Language Models & Generative AI. The records below separate source-reported results from evidence the source did not provide.

Last updated
Maintained by
Peter KorpakLead Editor
5
Case Studies
2
Use Case Types
2
Technologies

AI implementations at Bristol Myers Squibb

B
Pharmaceutical & Life ScienceDrug Discovery & DevelopmentMachine Learning & Predictive Analytics
Reported result:
~3% of ~20,000 human protein-coding genes Druggable Proteome Coverage (Current)
Deployment timeframe:
Not reported by source
Technology:
Machine Learning & Predictive Analytics
Vendor:
Not available in record
Cited source: www.bms.comSource link checked Automated evidence gate passed
B
Pharmaceutical & Life ScienceClinical Trials & ResearchLarge Language Models & Generative AI
Reported result:
Under 100 to nearly 900 users in 3 months Platform User Growth
Deployment timeframe:
Not reported by source
Technology:
Large Language Models & Generative AI
Vendor:
Not available in record
Cited source: www.accenture.comSource link checked Automated evidence gate passed
B
Pharmaceutical & Life ScienceDrug Discovery & DevelopmentMachine Learning & Predictive Analytics
Reported result:
100% (up from 5% in 2021) Small Molecule Programs Using AI Pre-Synthesis
Deployment timeframe:
Not reported by source
Technology:
Machine Learning & Predictive Analytics
Vendor:
Not available in record
Cited source: www.pharmavoice.comSource link checked Automated evidence gate passed

More in Pharmaceutical & Life Science

Insilico Medicine5Pfizer3AstraZeneca3Merck & Co.1Bayer1Merck1Mankind Pharma1University of Helsinki1Sumitomo Dainippon Pharma1Sanofi1